SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Crowd silhouettes reach toward a raised trophy beneath a vivid sunset sky, showing shared ambition, victory, teamwork, celebration, and success with open space for text.
Weight loss
Lilly’s triple agonist shows bariatric surgery–like weight loss results
Lilly met analysts’ sky-high expectations with 28.3% weight loss over 80 weeks for the triple hormone receptor agonist retatrutide in a highly anticipated readout on Thursday.
May 21, 2026
 · 
3 min read
 · 
Annalee Armstrong
Fight versus pop art comic red blue background with halftone, rays, hands holding paper. Vector cartoon illustration in retro style. Design for comic book, poster, banner, competition
Leadership
Vaxart seeks shareholder support as battle over stock split brews
In September last year, a group of concerned stockholders raised alarm about Vaxart’s proposed reverse stock split, which the biotech was pushing for despite strong opposition from shareholders.
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac
A human hand and a robot hand shake hands over a white circle on a green background
Artificial intelligence
Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
A trifecta of newly inked tech partnerships—from Eli Lilly, Bristol Myers Squibb and Incyte—exemplify the increasingly central role that AI is playing in drug development.
May 21, 2026
 · 
3 min read
 · 
Tristan Manalac
Stock market rebound, overcome business down fall and grow up profit or leadership and achievement concept, businessman jump bouncing high on trampoline with green rising up performance arrow graph.
Rare diseases
BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication
After being hit by safety issues and subpar results in another trial, BioMarin’s Phase 3 test of Voxzogo for a rare skeletal disorder called hypochondroplasia showed efficacy “solidly above” what the drug has shown for achondroplasia, which causes dwarfism.
May 21, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Inside Germany’s biotech capital infrastructure and innovation engine
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Andera Life Sciences. They explore Germany’s biotech and life sciences ecosystem, including the science, infrastructure and policy changes needed to help European companies scale globally while staying rooted in Europe.
May 21, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Illustration of businessman running on hamster wheel reaching for money held by giant hand
Job Trends
Biopharma professionals increasingly accept underemployment
The number of biotech and pharma professionals taking jobs they’re overqualified for is now over 50%, based on a BioSpace LinkedIn poll. A recruiting firm executive discusses the trend, the reasons behind it and why it doesn’t have to derail careers.
May 21, 2026
 · 
5 min read
 · 
Angela Gabriel
A mother affection flat round icon, editable download
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
Eli Lilly joins hands with Engage Bio, acquiring the DNA delivery platform developer in hopes of bolstering its genetic medicines portfolio.
May 20, 2026
 · 
2 min read
 · 
Gabrielle Masson
Email envelope with warning sign on white background
Manufacturing
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.”
May 20, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Richard Pazdur
Regulatory
Pazdur declines to announce candidacy for vacated FDA commissioner role
FDA veteran Richard Pazdur outlined his priorities for the next FDA commissioner but stopped short of putting himself forward as a candidate to lead the agency at an RBC Capital Markets event on Tuesday.
May 20, 2026
 · 
4 min read
 · 
Heather McKenzie
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS